Simonetta Marucci, Luca Busetto, Marco Chianelli, Alessandra Fusco, Maria Carpentieri, Marina Armellini, Francesco Tassone, Marcello Sciaraffia, Maria Chantal Ponziani, A. Nelva, Carla Micaela Cuttica
{"title":"Screening, Diagnosis, and Treatment of Patients with Binge Eating Disorder and Obesity: What the Endocrinologist Needs to Know","authors":"Simonetta Marucci, Luca Busetto, Marco Chianelli, Alessandra Fusco, Maria Carpentieri, Marina Armellini, Francesco Tassone, Marcello Sciaraffia, Maria Chantal Ponziani, A. Nelva, Carla Micaela Cuttica","doi":"10.3390/endocrines5010006","DOIUrl":null,"url":null,"abstract":"Binge eating disorder (BED) is the most common eating disorder categorized in the DSM-V, but it is often not diagnosed in patients with obesity because it can be difficult to detect in these patients who often have altered eating patterns. In this narrative review, we have highlighted the most recent findings in the screening, diagnosis, and treatment of patients with BED and obesity. The results of our search showed that many BED patients are not obese, and most people with obesity do not have binge behavior. In the diagnostic assessment of these patients, it is important to evaluate not only the clinical and nutritional status and the presence of medical comorbidities, but also the psychological signs and symptoms related to psychiatric comorbidities to define the appropriate diagnosis and the consequent level of treatment. Well-tolerated drugs with action on both body weight and binges can be useful as a second-line complement to cognitive behavioral therapy (CBT). Specific guidelines are needed to obtain consensus on appropriate recommendations in patients with obesity and BED approaching bariatric surgery, taking into account not only weight reduction and clinical data, but also eating behaviors. Identification of BED is important for targeting individuals at high risk of obesity, adverse metabolic patterns, and cardiovascular disease. The challenge is to also achieve lasting weight loss in patients with BED and concomitant obesity.","PeriodicalId":72908,"journal":{"name":"Endocrines","volume":"33 5-6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrines","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/endocrines5010006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Binge eating disorder (BED) is the most common eating disorder categorized in the DSM-V, but it is often not diagnosed in patients with obesity because it can be difficult to detect in these patients who often have altered eating patterns. In this narrative review, we have highlighted the most recent findings in the screening, diagnosis, and treatment of patients with BED and obesity. The results of our search showed that many BED patients are not obese, and most people with obesity do not have binge behavior. In the diagnostic assessment of these patients, it is important to evaluate not only the clinical and nutritional status and the presence of medical comorbidities, but also the psychological signs and symptoms related to psychiatric comorbidities to define the appropriate diagnosis and the consequent level of treatment. Well-tolerated drugs with action on both body weight and binges can be useful as a second-line complement to cognitive behavioral therapy (CBT). Specific guidelines are needed to obtain consensus on appropriate recommendations in patients with obesity and BED approaching bariatric surgery, taking into account not only weight reduction and clinical data, but also eating behaviors. Identification of BED is important for targeting individuals at high risk of obesity, adverse metabolic patterns, and cardiovascular disease. The challenge is to also achieve lasting weight loss in patients with BED and concomitant obesity.
暴饮暴食症(BED)是 DSM-V 分类中最常见的饮食失调症,但肥胖症患者往往不能确诊为暴饮暴食症,因为肥胖症患者的饮食模式经常发生改变,很难发现暴饮暴食症。在这篇叙述性综述中,我们重点介绍了在筛查、诊断和治疗 BED 和肥胖症患者方面的最新研究成果。我们的研究结果表明,许多 BED 患者并不肥胖,大多数肥胖症患者也没有暴饮暴食行为。在对这些患者进行诊断评估时,不仅要评估临床和营养状况以及是否存在内科合并症,还要评估与精神科合并症相关的心理症状和体征,以确定适当的诊断和相应的治疗水平。作为认知行为疗法(CBT)的二线补充,对体重和暴饮暴食均有作用的耐受性良好的药物可以发挥作用。对于即将接受减肥手术的肥胖症和 BED 患者,需要制定具体的指南,以就适当的建议达成共识,不仅要考虑减轻体重和临床数据,还要考虑进食行为。对于肥胖、不良代谢模式和心血管疾病高风险人群来说,识别 BED 非常重要。同时,如何使 BED 和合并肥胖症的患者实现持久的体重减轻也是一项挑战。